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(Director: Prof. Dr. KoICHI IsHIGAMI) 
The regenerative activity of the cirrhotic liver parenchyma after partial hepatectomy is 
markedly poor, and clinically liver surgery is quantitatively restricted because that hepatocellular 
carcinoma is usually accompanied with liver cirrhosis. It has been generally recognized that 
administration of glucagon and insulin stimulates the regeneration of residual liver. These 
hepatotrophic factors, however, seem to be not so effective for cirrhotic liver. The author 
supposed the receptors of these factors may be damaged in cirrhotic liver hepatocytes and studied 
the uptake oftransportally injected i2s1-labelled insulin into normal or cirrhotic rat liver hepato-
cytes. Further, the author examined the effectiveness of glucagon, insulin and prostaglandin 
E1, as hepatotrophic factors, to the rat liver regeneration after 70% partial hepatectomy. The 
results were as follows: 
1) DNA synthesis rates in residual livers at 24 hours after hepatectomy were ac氾eleratedby 
administration of glucagひnand insulin. However, glucagon and insulin seemed to be not 
so effective for cirrhotic livers. 
2) Prostaglandin E1 stimulated hepatic regeneration in normal livers only, but in cirrhotic 
livers, DNA synthesis rates were markedly accelerated using with glucagon and insulin. 
3) There was a tendency to inhibit the increase of serum GOT, G PT and ALP by administration 
of glucagon and insulin, or glucagon, insulin and prostaglandin E1・
Keywひ地： Experimental !iv町 cirhosis,Hepatic regeneration, Glucagon and Insulin, Prostaglandin E1, Insulin 
receptor. 
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4) In normal livers, uptake of 12s1・insulininto hepatocytes was more active than in cirrhotic 
livers. 
The present study indicates that administration of prostaglandin E1 with glucagon and 
insulin is effective to cirrhotic liver regeneration and that insulin receptors may be sustained some 
































































(Perista Pump, SJ・1211,A TTO) IC接続し，図rn:
示す輸液を行った．更に実験目的に応じて，輸液中IL
PGE1 (Prostandin，小野） 1 μg/100 g体重／day，グルカ
ゴン（glucagon,Novo) 0. 1 mg/100 g体重／day，イン
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GI ；グルカゴンー イ ンスリン群
GI+P：グルカゴンーインスリン＋PGE1群
































I.対照群 39. 8±1. 03 36.3土1.50 
* 
I. PGE1群 40. 8±1. 512 36. 8土1.85 
il. GI群 i
IV. GI+PGE1群！


































GOT (U) GPT (U) LDH (U) ALP (U) TP (g/dl) 
術 前 68.8± 19. 7 23.3土 14.2 270.8土123.4 55.5土 19.7 6.2土0.5
対照群 544. 0±123.。283.6土107.8 477. 6±301. 4 174.4士 80.6 5. 0±0. 5 
PGE1群 410. 4±104. 6 238. 8± 67. 7 409.6土146.6 126.1土 25.4 4. 7±0. 5 
GI群 288. 0 ± 62. 9** 170.0士 89.0* 378.2士159.8 62.0士 24.4** 4.6土0.4
GI+PGE1群 301. 8土 88.5** 207.6土 60.4 330.4土105.1 74.1士 10.4** 5.0土0.7 
(Value of x士S.E. n=5) (*p<O. 05，帥p<O.01) 
表3 血液生化学検査（肝切後24時間，硬変肝群）
GOT (U) GPT (U) LDH (U) ALP (U) TP (g/dl) 
術 前 161. 8± 29. 8 57.0土 25.0 505.0土 87.9 71. 8± 2. 9 5. 7±0. 5 
対照群 532.5士247.。219. 0±120. 3 603.8土313.7 128.4土 52.2 4.9土0.2
PGE1群 439.0土139.1 210. 8± 82. 0 394.5士202.。101. 7± 2. 4 4.6土0.8
GI群 316.3土103.3* 159.5土 49.6 395.8土102.7 86.2土 53.4 4. 4±0. 6 
GI十PGE1群 367.8± 96. 9 154. 3± 31. 2 308.3土134.9* 95.2土 19.6 4.8土0.4
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